Member Info for jamrock

Https://onlinedoctor.boots.com/home-testing-kits?utm_source=Boots&utm_medium=referral&utm_campaign=Boots_testing_kits

With the heavy investment in digital data and test on the shelves in Boots I wonder how long before we announce a new collaboration between Boots, the NHS Doctors and GPs and MHC tests in stores where appropriate.

There must be a reason for only 801 selected for initial roll out.

Is the a monitoring exercise!

Will this develop into a wider arrangement!.

Seams very plausible given the savings on NHS resources

Https://www.google.com/search?q=what+does+it+cost+the+NHS+for+each+patient+that+has+a+blood+test&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari

The average standard blood test costs the NHS £10.00

To get GP appointment takes days or weeks depending on postcode usually!!.

Then the referral etc and costs to nurse etc.

Time taken up in hospitals if your referred.

Then usually another trip back to GP for results.

Surely MHC are aware of the process and costs and see the future in wellness and wellbeing.

MHC could be onto a real winner with Boots if they expand the service.

The time and money and hours freed up for NHS professionals would take a huge strain off the NHS.

The chairman’s statement in August mentions the NHS so I’m sure they are working on something.

This is also by the emphasis on phlebotomy testing and need to comply with standards to meet HIW.

I hope Penny realises private tests is a winner but also providing a service to the NHS would send revenue to another level.

Paul

The thing is we had a pandemic as a result of Chinese lack of ability to control it.

The fact is many initial covid companies have gone bust or been swallowed up.

MHC was always going to be a wellbeing company and made it clear Covid was a means to help it on the journey.

The journey has been a painful one 100% because market sentiment has changed due to inflation and a war in Europe!.

The facts are we have emerged stronger from the pandemic and truly established our footing in the sector. We are financially solid and self sufficient. No investor dilution and cash rich in many ways.

Fixtures and fittings in 801 stores fully paid. Products fully paid and digital data growing.

We met HIW standards and in a position to truly expand things.

There’s certainly risk as in all AIM companies but is it on the right track and have the board been prudent or waist full. I’d say Penny has been exceptional and prudent and steering us through difficult macroeconomic times and we could be one of the tru growth stories if we survive independently without a takeover from arrivals.

If one bought in the height of the pandemic why wouldn’t you buy at a 90% discount and in a stronger position with actual products now seeing traction.

I would like to see Directors buy buying but that’s personal choice.

It will be bumpy as Covid Revenue has peaks and troughs but we must believe true revenue from new products can slowly be extracted.

Https://m.youtube.com/watch?v=w4nwU-mB9EY&pp=ygUKY292aWQgbmV3cw%3D%3D

Whatever happens we must realise COVID revenue has seriously helped investors value in the longer term. Short term we all feel the share price is way to low but I’m sure it will eventually rise but we 100% could do with positive news as regards new product sales.

Once the market sees a clear strategy it will attract larger buyers but as I’ve stated before only 52 shares in circulation and many of them tied up.

Good news would create a squeeze. The recent fall was on very little shares sold .

It would be nice for a steady rise in my opinion.

Amber

Based on average 3 tests sold in each store combined between 5pk and single ones sold in average 2500 stores between Boots and Lloyds and average daily sales on I would say the month of January will be closer to 1m revenue.

What excites me is the fact the new product are also being sold in 801 stores. We have also paid for all the racking in the stores so the real growth is getting traction in footfall in stores.

We then have an option to expand into many more stores if demand warrants it.

I 100 believe a deal allowing us to work with Boots to complete immediate testing in established booths already in place which could open the doors for patients being sent to use our facilities. The fact we have everything in place and meet necessary requirements.

I know they have continued to state the strategy is private testing I’m sure Penny is aware this would be explosive stuff.

After all she was smart enough to move in LFT from PCR which has enabled growth with dilution to share holders.

All possibilities at the moment but don’t rule anything out. Even a takeover

Covid and lockdown has changed the game

Can some one do a calculation of how much Revenue we would make if 801 stores sold just 1 test in each range each day for 52 weeks!.

Well I tell you the intolerance test would be over 15m alone at just 1 test per day for 52 weeks in 801 stores.

Then we have online sales.

So we can see the potential for growth is truly incredible.

I do fully see MHC going out for growth in the new products in 2024.

It will be driven by a up beat guidance in sales in new products.

Https://www.boots.com/myhealthchecked-intolerances-sensitivities-dnatest-10322824

So 9 sold in the last 24 hrs at £54.00 each

Some say that’s nothing.

They are in 801 stores along with the other new lines.

801 x 4 tests x 7 days a week x 52 week X £54.00 each =

How many millions!!!!!

Online these weren’t selling a month ago and now we can see what traction means.

Online is a guide but instore is the growth potential.

Nearly 2000 Boots nationwide!

If your short term then it’s not for you but medium to long term holders understand the potential.

People are sick of the NHS.

I see this exploding but i believe in the strategy and don’t mind pull backs

The potential to ramp this up to another level is clear to see. I just just hope MHC can handle it.

Then imagine if NHS get approved to get tests on the NHS and use the facilities in Boots to get the tests same day.

MHC are meeting all the guidelines to allow this.

Do people really believe Penny hasn’t thought it through.

You won’t get figures as regards new products until March.

Don’t really see a panic.

MHC just need to keep producing decent figures and leave the rest upto the market and see when sentiment changes.

Many companies on the AIM with no revenue however much greater valuation.

They need to keep diluting to stay afloat so I’m comfortable with MHC financially by equally disappointed with share price like most investors

Kosh

It all hangs on the 23rd

Some people are short term traders and others are long term.

I’m long term and happy to top up on pull backs so I take it I’m presented with a top up opportunity.

We will see how this turns out but I’m also disappointed with the pullback as I truly felt we had decent results and with such a low PE I hope we can move upwards soon enough when the few sellers from the 52 m shares are done.

Maybe Donald has another order he’s filling up lol.

Good luck and lose sleep as I’m certainly not and truly trust in Penny

SeedyG

You could be correct but my interpretation of ramping is putting up stuff without foundation. However I’m definitely fully loyal in my support for MHC.

Just over 400,000 shares sold from 52 million and you insinuate it’s ramping.

I don’t think our Donald who bought 1.5m million calls it ramping.lol

Some people are short m

Https://m.youtube.com/watch?v=7Sc30qRxlyo&pp=ygUKY292aWQgbmV3cw%3D%3D

So the Chinese are at it again.

How worried should we be!.

The world needs to realise more money needs to go into this sector as it’s easily conceivable that China could only be trying to weaponise disease.

Why would any country want to develop a Coronavirus that kills humans 100%.

This is definitely a worrying development and it’s definitely time to wake up to reality that Covid ain’t going away any year soon.

Morning all

It’s been a terrible week for MHC on less than £25,000 worth of share sales we’ve declined 20% thus wiping off over 1.5m off the market Csp!

Is this Justified!!!!!

Absolutely not.

The sector has an average P/E of 14 plus

MHC has a P/E of Just 4

So to my basic calculations we should be on a price of 40p as a comparison to sectors average.

Am I saying it will happen over night ! No because the market will require MHC demonstrating consistent revenue and profit increases.

Can MHC does this is the question?. Yes in IMO

The revenue is already showing traction on the boots site and with nearly 2000 stores and fact our products are only in 801 the opportunity with Boots alone is immense.

You must consider your strategy when investing in MHC but the track record of Penny has been outstanding and we must believe MHC will break out this year as the doors to well being is truly opened to the public. Many people more conscious of personal health in a stretched NHS.

I will only be adding in 2024 for the longer term.

Good luck all.

Https://m.youtube.com/watch?v=c2Un5d_JlT4

How worried should we all be with all these experiments and we all know the repercussions when something goes wrong.

Is it for the take Covid and new strains seriously as an ongoing threat and pump money into testing etc.

The don’t need another pandemic but we all need to know our loved ones are protected.

Private vaccines coming but I strongly suspect Boots will be encouraging more wellbeing testing soon.

Spindok

I for one would have liked and update as regards sales of new tests but in reality you won’t get anything regarding these until March/April as the figures on January 11th were just and update.

I believe that Penny has 2-3 Months to ensure a plan to promote and increase new products and use Covid Revenue to create growth. We all know that the growth plan of new products is crucial but any good news between now and March will cement trust in the strategy.

It clear there’s more traction but more figures and guidance would be appreciated and go down. Treat.

Also would be nice for Directors to show support but this has been said many times and none since 2022!.

Still plenty to be optimistic about especially as we have the cash for expansion.

Spindok

Just need to relax

It’s dropped to 12.5p on £16.000 worth of sells!

So that’s 2.5p!

That’s over a million in Market cap.

I personally am not worried because fundamentals are doing fine and generating cash.

The Markets will decide if they take it up or down and we just need to believe in the board

By mid February we would have generated more revenue than the first six months of 2023 and people selling.

Stay strong and believe in your investment.

Traction in new products 100%

As soon as news lands it will change course

Anyone who’s worried today about a small drop based on around £11,000 worth of share sales needs to take listen to this from WHO

https://m.youtube.com/watch?v=vQdQ2-WcEY4&pp=ygUKY292aWQgbmV3cw%3D%3D

Covid is significantly higher than reported and many countries not reporting deaths!.

Covid figures in December 10,000 deaths reported in just 50 countries, 5000 in the USA and 1000 in Italy.

January figures not out as yet but COVID expected to continue to evolve and kill as immunity wearing off.

MHC has 7.75 m in the bank and many said after last years results when they had 7m MHC would be out of cash.

Sorry they are growing cash while adding new product growth.

Many choose to bash MHC whilst others like me promote them.

I called MHC having 11 m revenue and between 7-8 m in the bank and I’m personally confident this will grow as new products gain traction which is evidenced by regular sales on Boots site.

Yes Covid sales will have peaks and throughs but one thing is for sure 4 years on it’s certainly not endemic as it continues to cause great public health concerns.

Today was interesting because despite all the negative chat only half the amount of shares traded and compared to past few days. A lot of AIM stocks hit today so imo it’s a blip on an uptrend started ion December 27th. No ones certain but as an investor averaging is key and when new contracts, Directors buying, RNS released people realisation and opinions can change swiftly. We rose to 16p and pulled back on minimum share trades.

I won’t be selling and will be taking advantage and happy to update when I do release funds to buy more.

No doubts many negative people will say differently but my average has dropped considerably because of buying low and continuing to support a company I believe in. How many Aim companies have vanished this year! How many many have more cash than last year.

Each to their own but I’m totally confident and will not waiver.